Luc Friboulet

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Topics

Small Cell Lung Cancer

Benign Prostatic Hyperplasia

Acute Lymphoblastic Leukemia

Top Venues

British journal of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ precision oncology

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Francesco Facchinetti, Yohann Loriot, Floriane Braye, Damien Vasseur, Rastislav Bahleda, Ludovic Bigot, Rémy Barbé, Catline Nobre, David Combarel, Stefan Michiels, Antoine Italiano, Cristina Smolenschi, Lambros Tselikas, Jean Yves Scoazec, Santiago Ponce-Aix, Benjamin Besse, Fabrice Andre, Ken A Olaussen, Antoine Hollebecque, Luc Friboulet
Understanding and Overcoming Resistance to Selective FGFR inhibitors Across FGFR2-Driven Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul, Aurélie Swalduz, Augusto Valdivia, Melissa Lynne Johnson, Benjamin Besse, D Ross Camidge, Toshio Fujino, Satoshi Yoda, Linh Nguyen-Phuong, Hayato Mizuta, Ludovic Bigot, Catline Nobre, Jii Bum Lee, Mi Ra Yu, Scot Mente, Yuting Sun, Nancy E Kohl, James R Porter, Matthew D Shair, Viola W Zhu, Enriqueta Felip Font, Byoung Chul Cho, Luc Friboulet, Aaron N Hata, Henry E Pelish, Alexander E Drilon
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations. Cancer discovery (2024)
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer 130 (4) (2024)
Damien Vasseur, Ahmadreza Arbab, Fabiola Giudici, Christophe Marzac, Stefan Michiels, Marco Tagliamento, Arnaud Bayle, Cristina Smolenschi, Madona Sakkal, Mihaela Aldea, Hela Sassi, Filippo Gustavo Dall'Olio, Noémie Pata-Merci, Sophie Cotteret, Alice Fiévet, Nathalie Auger, Luc Friboulet, Francesco Facchinetti, Arthur Géraud, Santiago Ponce, Antoine Hollebecque, Benjamin Besse, Jean Baptiste Micol, Antoine Italiano, Ludovic Lacroix, Etienne Rouleau
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients. NPJ precision oncology 8 (1) (2024)
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer 130 (4) (2024)
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer 130 (4) (2024)
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer 130 (4) (2024)
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer 130 (4) (2024)
Ursula Grazini, Aleksandra A Markovets, Lucy Ireland, Daniel O'Neill, Benjamin Phillips, Man Xu, Matthias Pfeifer, Tereza Vaclova, Matthew J Martin, Ludovic Bigot, Luc Friboulet, Ryan J Hartmaier, Maria Emanuela Cuomo, Simon T Barry, Paul D Smith, Nicolas Floc'h
Overcoming osimertinib resistance with AKT inhibition in EGFRm-driven Non-Small-Cell-Lung-Cancer with PIK3CA/PTEN alterations. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer 130 (4) (2024)
Damien Vasseur, Ahmadreza Arbab, Fabiola Giudici, Christophe Marzac, Stefan Michiels, Marco Tagliamento, Arnaud Bayle, Cristina Smolenschi, Madona Sakkal, Mihaela Aldea, Hela Sassi, Filippo Gustavo Dall'Olio, Noémie Pata-Merci, Sophie Cotteret, Alice Fiévet, Nathalie Auger, Luc Friboulet, Francesco Facchinetti, Arthur Géraud, Santiago Ponce, Antoine Hollebecque, Benjamin Besse, Jean Baptiste Micol, Antoine Italiano, Ludovic Lacroix, Etienne Rouleau
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients. NPJ precision oncology 8 (1) (2024)
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer (2024)
Yoann Pradat, Julien Viot, Andrey A Yurchenko, Konstantin Gunbin, Luigi Cerbone, Marc Deloger, Guillaume Grisay, Loic Verlingue, Veronique Chung-Scott, Ismael Padioleau, Leonardo Panunzi, Stefan Michiels, Antoine Hollebecque, Gerome Jules-Clement, Laura Mezquita, Antoine Laine, Yohann Loriot, Benjamin Besse, Luc Friboulet, Fabrice Andre, Paul-Henry Cournede, Daniel Gautheret, Sergey I Nikolaev
Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer. Cancer discovery (2023)
Naoual Menssouri, Loic Poiraudeau, Carole Helissey, Ludovic Bigot, Jonathan Sabio, Tony Ibrahim, Cedric Pobel, Claudio Nicotra, Maud Ngo-Camus, Ludovic Lacroix, Etienne Rouleau, Lambros Tselikas, Anne Chauchereau, Félix Blanc-Durand, Alice Bernard-Tessier, Anna Patrikidou, Natacha Naoun, Ronan Flippot, Emeline Colomba, Alina Fuerea, Laurence Albiges, Pernelle Lavaud, Paul van de Wiel, Eveline den Biezen-Timmermans, Yvonne J W Rozendaal, Santiago Ponce-Aix, Stefan Michiels, Christophe Massard, Daniel Gautheret, Fabrice Barlesi, Fabrice Andre, Benjamin Besse, Jean Yves Scoazec, Luc Friboulet, Karim Fizazi, Yohann Loriot
Genomic profiling of metastatic castration-resistant prostate cancer samples resistant to androgen-receptor pathway inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Julien Hadoux, Abir Al Ghuzlan, Livia Lamartina, Mohamed Amine Bani, Sophie Moog, Marie Attard, Jean Yves Scoazec, Dana M Hartl, Mihaela Aldea, Luc Friboulet, Gerome Jules-Clement, Antoine Italiano, Benjamin Besse, Ludovic Lacroix, Eric Baudin
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma. JCO precision oncology 7 (2023)
Julien Hadoux, Abir Al Ghuzlan, Livia Lamartina, Mohamed Amine Bani, Sophie Moog, Marie Attard, Jean Yves Scoazec, Dana M Hartl, Mihaela Aldea, Luc Friboulet, Gerome Jules-Clement, Antoine Italiano, Benjamin Besse, Ludovic Lacroix, Eric Baudin
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma. JCO precision oncology 7 (2023)
Francesco Facchinetti, Antoine Hollebecque, Floriane Braye, Damien Vasseur, Yoann Pradat, Rastislav Bahleda, Cedric Pobel, Ludovic Bigot, Olivier Deas, Juan David Florez Arango, Giorgia Guaitoli, Hayato Mizuta, David Combarel, Lambros Tselikas, Stefan Michiels, Sergey I Nikolaev, Jean Yves Scoazec, Santiago Ponce-Aix, Benjamin Besse, Ken A Olaussen, Yohann Loriot, Luc Friboulet
Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer. Cancer discovery (2023)
Patricia Martin-Romano, Laura Mezquita, Antoine Hollebecque, Ludovic Lacroix, Etienne Rouleau, Anas Gazzah, Rastilav Bahleda, David Planchard, Andrea Varga, Capucine Baldini, Sophie Postel-Vinay, Luc Friboulet, Yohann Loriot, Loic Verlingue, Arthur Geraud, Maud Ngo Camus, Claudio Nicotra, Jean Charles Soria, Fabrice André, Benjamin Besse, Christophe Massard, Antoine Italiano
Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology. JCO precision oncology 6 (2022)
Hayato Mizuta, Koutaroh Okada, Mitsugu Araki, Jun Adachi, Ai Takemoto, Justyna Kutkowska, Kohei Maruyama, Noriko Yanagitani, Tomoko Oh-Hara, Kana Watanabe, Keiichi Tamai, Luc Friboulet, Kazuhiro Katayama, Biao Ma, Yoko Sasakura, Yukari Sagae, Mutsuko Kukimoto-Niino, Mikako Shirouzu, Satoshi Takagi, Siro Simizu, Makoto Nishio, Yasushi Okuno, Naoya Fujita, Ryohei Katayama
Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer. Nature communications 12 (1) (2021)
Gonzalo Recondo, Linda Mahjoubi, Aline Maillard, Yohann Loriot, Ludovic Bigot, Francesco Facchinetti, Rastislav Bahleda, Anas Gazzah, Antoine Hollebecque, Laura Mezquita, David Planchard, Charles Naltet, Pernelle Lavaud, Ludovic Lacroix, Catherine Richon, Aurelie Abou Lovergne, Thierry De Baere, Lambros Tselikas, Olivier Deas, Claudio Nicotra, Maud Ngo-Camus, Rosa L Frias, Eric Solary, Eric Angevin, Alexander Eggermont, Ken A Olaussen, Gilles Vassal, Stefan Michiels, Fabrice Andre, Jean-Yves Scoazec, Christophe Massard, Jean-Charles Soria, Benjamin Besse, Luc Friboulet
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy. NPJ precision oncology 4 (2020)
Sandra Ortiz-Cuaran, Laura Mezquita, Aurélie Swalduz, Mihalea Aldea, Julien Mazieres, Camille Leonce, Cecile Jovelet, Anne Pradines, Virginie Avrillon, Washington R Chumbi Flores, Ludovic Lacroix, Yohann Loriot, Virginie Westeel, Maud Ngo-Camus, Claire Tissot, Christine Raynaud, Radj Gervais, Etienne G C Brain, Isabelle Monnet, Etienne Giroux Leprieur, Caroline Caramella, Celine Mahier-Aït Oukhatar, Natalie Hoog-Labouret, Frank de Kievit, Karen Howarth, Clive Morris, Emma Green, Luc Friboulet, Sylvie Chabaud, Jean-François Guichou, Maurice Pérol, Benjamin Besse, Jean Yves Blay, Pierre Saintigny, David Planchard
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF-Mutant Metastatic Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Ian M Silverman, Antoine Hollebecque, Luc Friboulet, Sherry Owens, Robert C Newton, Huiling Zhen, Luis Féliz, Camilla Zecchetto, Davide Melisi, Timothy C Burn
Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib. Cancer discovery 11 (2) (2020)
Gonzalo Recondo, Linda Mahjoubi, Aline Maillard, Yohann Loriot, Ludovic Bigot, Francesco Facchinetti, Rastislav Bahleda, Anas Gazzah, Antoine Hollebecque, Laura Mezquita, David Planchard, Charles Naltet, Pernelle Lavaud, Ludovic Lacroix, Catherine Richon, Aurelie Abou Lovergne, Thierry De Baere, Lambros Tselikas, Olivier Deas, Claudio Nicotra, Maud Ngo-Camus, Rosa L Frias, Eric Solary, Eric Angevin, Alexander Eggermont, Ken A Olaussen, Gilles Vassal, Stefan Michiels, Fabrice Andre, Jean-Yves Scoazec, Christophe Massard, Jean-Charles Soria, Benjamin Besse, Luc Friboulet
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy. NPJ precision oncology 4 (1) (2020)
Francesco Facchinetti, Antoine Hollebecque, Rastislav Bahleda, Yohann Loriot, Ken A Olaussen, Christophe Massard, Luc Friboulet
Facts and New Hopes on Selective FGFR Inhibitors in Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (4) (2019)
Gonzalo Recondo, Francesco Facchinetti, Ken A Olaussen, Benjamin Besse, Luc Friboulet
Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI? Nature reviews. Clinical oncology 15 (11) (2019)
Francesco Facchinetti, Luc Friboulet
Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date. Lung Cancer (Auckland, N.Z.) 10 (2019)
Bo Gong, Kazuma Kiyotani, Seiji Sakata, Seiji Nagano, Shun Kumehara, Satoko Baba, Benjamin Besse, Noriko Yanagitani, Luc Friboulet, Makoto Nishio, Kengo Takeuchi, Hiroshi Kawamoto, Naoya Fujita, Ryohei Katayama
Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer. The Journal of experimental medicine 216 (4) (2019)
Leila Dardaei, Hui Qin Wang, Manrose Singh, Paul Fordjour, Katherine X Shaw, Satoshi Yoda, Grainne Kerr, Kristine Yu, Jinsheng Liang, Yichen Cao, Yan Chen, Michael S Lawrence, Adam Langenbucher, Justin F Gainor, Luc Friboulet, Ibiayi Dagogo-Jack, David T Myers, Emma Labrot, David Ruddy, Melissa Parks, Dana Lee, Richard H DiCecca, Susan Moody, Huaixiang Hao, Morvarid Mohseni, Matthew LaMarche, Juliet Williams, Keith Hoffmaster, Giordano Caponigro, Alice T Shaw, Aaron N Hata, Cyril H Benes, Fang Li, Jeffrey A Engelman
SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors. Nature medicine 24 (4) (2018)